当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Guggul Lipid Solid Lipid Nanoparticles as a Promising Drug Carrier for Transdermal Drug Delivery

Hitesh Kifle

Diclofenac sodium-loaded solid lipid nanoparticles with guggul lipid as the main lipid component were created and tested for physical characteristics, permeation profile, and anti-inflammatory action. The SLNs were formed into gel after being assessed for physical parameters, in vitro drug release, and accelerated stability experiments. For ex vivo and in vivo drug penetration and anti-inflammatory effectiveness, the gels were compared to a commercial emulgel and a plain carbopol gel containing drug. The SLNs were stable and had ideal physical properties. The maximum in vitro drug release was achieved by GMS nanoparticle 1 and stearic acid nanoparticle 1. In receptor fluid, guggul lipid nanoparticle gel 3 had 104.68 times more drug than CEG. The enhancement ratio of GLNG-3 in comparison to CG was 39.43. At 4 hours, GLNG-3 was over 8.12 times greater than CEG. The AUC of GLNG-3 was 15.28 times greater than that of CEG.